File Justin J. 4
4 · Evofem Biosciences, Inc. · Filed Jun 15, 2020
Insider Transaction Report
Form 4
File Justin J.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-06-12$3.14/sh+8,500$26,690→ 250,408 total
Footnotes (1)
- [F1]The total amount of securities beneficially owned includes 4,303 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period.